Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients.

Zeka F, Decock A, Van Goethem A, Vanderheyden K, Demuynck F, Lammens T, Helsmoortel HH, Vermeulen J, Noguera R, Berbegall AP, Combaret V, Schleiermacher G, Laureys G, Schramm A, Schulte JH, Rahmann S, Bienertová-Vašků J, Mazánek P, Jeison M, Ash S, Hogarty MD, Moreno-Smith M, Barbieri E, Shohet J, Berthold F, Van Maerken T, Speleman F, Fischer M, De Preter K, Mestdagh P, Vandesompele J.

JCI Insight. 2018 Dec 6;3(23). pii: 97021. doi: 10.1172/jci.insight.97021.

2.

Long noncoding RNA expression profiling in cancer: Challenges and opportunities.

Lorenzi L, Avila Cobos F, Decock A, Everaert C, Helsmoortel H, Lefever S, Verboom K, Volders PJ, Speleman F, Vandesompele J, Mestdagh P.

Genes Chromosomes Cancer. 2019 Apr;58(4):191-199. doi: 10.1002/gcc.22709. Epub 2019 Jan 20. Review.

PMID:
30461116
3.

Stage 4S neuroblastoma tumors show a characteristic DNA methylation portrait.

Decock A, Ongenaert M, De Wilde B, Brichard B, Noguera R, Speleman F, Vandesompele J.

Epigenetics. 2016 Oct 2;11(10):761-771. doi: 10.1080/15592294.2016.1226739.

4.

Sarcoidosis-Like Lesions: Another Paradoxical Reaction to Anti-TNF Therapy?

Decock A, Van Assche G, Vermeire S, Wuyts W, Ferrante M.

J Crohns Colitis. 2017 Mar 1;11(3):378-383. doi: 10.1093/ecco-jcc/jjw155. Review.

PMID:
27591675
5.

MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma.

Fabian J, Opitz D, Althoff K, Lodrini M, Hero B, Volland R, Beckers A, de Preter K, Decock A, Patil N, Abba M, Kopp-Schneider A, Astrahantseff K, Wünschel J, Pfeil S, Ercu M, Künkele A, Hu J, Thole T, Schweizer L, Mechtersheimer G, Carter D, Cheung BB, Popanda O, von Deimling A, Koster J, Versteeg R, Schwab M, Marshall GM, Speleman F, Erb U, Zoeller M, Allgayer H, Simon T, Fischer M, Kulozik AE, Eggert A, Witt O, Schulte JH, Deubzer HE.

Oncotarget. 2016 Oct 11;7(41):66344-66359. doi: 10.18632/oncotarget.11662.

6.

DNA methylation profiling of primary neuroblastoma tumors using methyl-CpG-binding domain sequencing.

Decock A, Ongenaert M, Van Criekinge W, Speleman F, Vandesompele J.

Sci Data. 2016 Feb 2;3:160004. doi: 10.1038/sdata.2016.4.

7.

Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma.

Decock A, Ongenaert M, Cannoodt R, Verniers K, De Wilde B, Laureys G, Van Roy N, Berbegall AP, Bienertova-Vasku J, Bown N, Clément N, Combaret V, Haber M, Hoyoux C, Murray J, Noguera R, Pierron G, Schleiermacher G, Schulte JH, Stallings RL, Tweddle DA; Children’s Cancer and Leukaemia Group (CCLG), De Preter K, Speleman F, Vandesompele J.

Oncotarget. 2016 Jan 12;7(2):1960-72. doi: 10.18632/oncotarget.6477.

8.

[Robotical laparoscopic nephrectomy for living donors].

Pavard D, Decock A, Bruyère F.

Prog Urol. 2015 Nov;25(14):892-9. doi: 10.1016/j.purol.2015.09.015. Epub 2015 Oct 23. French.

PMID:
26471213
9.

Photoselective Vaporization of the Prostate in Men With Refractory Urinary Retention.

Pradère B, Peyronnet B, Decock A, Brichart N, Bertrand P, Bruyère F.

Urology. 2015 Jul;86(1):145-50. doi: 10.1016/j.urology.2015.04.020.

PMID:
26142599
10.

A bone scan, no mistake!

Decock A, De Geeter F, De Vriese A, Depaepe P, Van den Bruel A.

J Clin Endocrinol Metab. 2014 Dec;99(12):4447-8. doi: 10.1210/jc.2014-2915. No abstract available.

PMID:
25250637
11.

Prosbiotate: a multicenter, prospective analysis of infectious complications after prostate biopsy.

Bruyère F, Malavaud S, Bertrand P, Decock A, Cariou G, Doublet JD, Bernard L, Bugel H, Conquy S, Sotto A, Boiteux JP, Pogu B, Rebillard X, Mongiat-Artus P, Coloby P.

J Urol. 2015 Jan;193(1):145-50. doi: 10.1016/j.juro.2014.07.086. Epub 2014 Jul 22.

PMID:
25063492
12.

Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers.

Decock A, Ongenaert M, Hoebeeck J, De Preter K, Van Peer G, Van Criekinge W, Ladenstein R, Schulte JH, Noguera R, Stallings RL, Van Damme A, Laureys G, Vermeulen J, Van Maerken T, Speleman F, Vandesompele J.

Genome Biol. 2012 Oct 3;13(10):R95. doi: 10.1186/gb-2012-13-10-r95.

13.

Structural determinants of MALT1 protease activity.

Wiesmann C, Leder L, Blank J, Bernardi A, Melkko S, Decock A, D'Arcy A, Villard F, Erbel P, Hughes N, Freuler F, Nikolay R, Alves J, Bornancin F, Renatus M.

J Mol Biol. 2012 May 25;419(1-2):4-21. doi: 10.1016/j.jmb.2012.02.018. Epub 2012 Feb 23.

14.

Neuroblastoma epigenetics: from candidate gene approaches to genome-wide screenings.

Decock A, Ongenaert M, Vandesompele J, Speleman F.

Epigenetics. 2011 Aug;6(8):962-70. doi: 10.4161/epi.6.8.16516. Epub 2011 Aug 1. Review.

PMID:
21725203
15.

The crystal structure of caspase-6, a selective effector of axonal degeneration.

Baumgartner R, Meder G, Briand C, Decock A, D'arcy A, Hassiepen U, Morse R, Renatus M.

Biochem J. 2009 Oct 12;423(3):429-39. doi: 10.1042/BJ20090540.

PMID:
19694615
16.
17.

Soy protein isolates in hypoallergenic infant formulations and humanized milks.

Decock A.

J Am Oil Chem Soc. 1974 Jan;51(1):199A-200A. No abstract available.

PMID:
4856016

Supplemental Content

Loading ...
Support Center